Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

NYU grants Medco option to license adenosine A2 agonists

June 16, 1997

Cellegy discovers compounds that modulate topical inflammatory and allergic responses

June 16, 1997

Favorable preclinical results with REPEL-CV for cardiovascular surgery

June 13, 1997

Merck & Co. continues to develop 5alpha-reductase inhibitors

June 11, 1997

Inhibitors of 5alpha-reductase prepared by Merck & Co.

June 10, 1997

Preparation and use of 5alpha-reductase type 1 inhibitors described by Merck & Co.

June 6, 1997

Penederm receives SBIR grant for research on vitamin D derivative

June 5, 1997

Bristol-Myers Squibb selects diacid for development as antipsoriatic

June 4, 1997

ProCyte launches GraftCyte products

May 28, 1997

Dusa reports progress in phase III trial of Levulan PDT

May 23, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...